Immediate Impact

1 by Nobel laureates 71 standout
Sub-graph 1 of 23

Citing Papers

The anti-PD-L1/CTLA-4 bispecific antibody KN046 plus lenvatinib in advanced unresectable or metastatic hepatocellular carcinoma: a phase II trial
2025 Standout
Latest advances in hepatocellular carcinoma management and prevention through advanced technologies
2024 Standout
1 intermediate paper

Works of Juichi Takada being referenced

Early increase in α-fetoprotein for predicting unfavorable clinical outcomes in patients with advanced hepatocellular carcinoma treated with sorafenib
2013

Author Peers

Author Last Decade Papers Cites
Juichi Takada 446 278 147 24 529
Yusuke Okuwaki 496 298 170 23 567
Noriaki Naeshiro 386 309 176 25 546
Ei Itobayashi 474 339 122 32 589
Daisuke Miyaki 378 278 136 24 501
Katsuhisa Nakatsuka 328 334 191 27 565
Eleonora Terzi 515 305 164 22 643
Yoshimichi Chuganji 296 187 93 31 503
Marc Puigvehí 347 258 89 24 493
Luigi Sandonato 217 172 208 27 511
Angel Alsina 314 273 153 32 459

All Works

Loading papers...

Rankless by CCL
2026